You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adrenergic beta-Antagonists

Showing 1 - 25 of 4,564
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Fibrillation, Persistent Trial in Canada (Cryoballoon-based PVI,

Active, not recruiting
  • Atrial Fibrillation
  • +12 more
  • Cryoballoon-based PVI
  • Anti-Arrhythmic Drug Therapy
  • Calgary, Alberta, Canada
  • +17 more
Aug 22, 2022

Healthy Trial in Maastricht (Clenbuterol Hydrochloride, Placebos)

Completed
  • Healthy
  • Clenbuterol Hydrochloride
  • Placebos
  • Maastricht, Limburg, Netherlands
    Maastricht University
Nov 28, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Tobacco Use Disorder, Nicotine Dependence, Cigarette Smoking Trial in Tulsa (Propranolol, Nicotine Patch, Placebo Propranolol)

Not yet recruiting
  • Tobacco Use Disorder
  • +2 more
  • Tulsa, Oklahoma
    Hardesty Center for Clinical Research and Neuroscience
Oct 18, 2022

Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)

Recruiting
  • Thermogenesis
  • Basel, Switzerland
    University Hospital Basel, Dept. of Endocrinology
Apr 27, 2022

Obesity, Prediabetes Trial in La Jolla (Mirabegron)

Not yet recruiting
  • Obesity, Prediabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022

Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)

Not yet recruiting
  • Voiding Disorders
  • Overactive Bladder
  • Beta3-Agonists, Adrenergic
  • Anticholinergic drug, Solifenacin
  • (no location specified)
Feb 13, 2022

Chronic Diabetic Foot Ulcers, Diabetic Neuropathic Ulcers, Non Healing Wound Trial in Sacramento (Timolol, Non biologically

Recruiting
  • Chronic Diabetic Foot Ulcers
  • +2 more
  • Sacramento, California
    VA Northern California Health Care System, Mather, CA
Mar 16, 2022

Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Formoterol Fumarate 12 micrograms Inhalation Powder
  • +8 more
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Sep 22, 2022

Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])

Not yet recruiting
  • Urgency Urinary Incontinence
  • Beta3-Agonists, Adrenergic
  • OnabotulinumtoxinA 100 UNT [Botox]
  • Birmingham, Alabama
  • +4 more
Mar 28, 2023

Cardiomyopathy, Dilated, Heart Failure, Autoantibodies Trial in Belgrade, Belgrad (BC 007)

Active, not recruiting
  • Cardiomyopathy, Dilated
  • +2 more
  • BC 007
  • Belgrade, Serbia
  • +2 more
Jul 19, 2022

Cervical Cancer Trial in Houston (Propranolol, Diary, Relaxation Audio Recording)

Terminated
Has Results
  • Cervical Cancer
  • Houston, Texas
  • +1 more
Sep 15, 2021

STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
  • Left Ventricular Systolic Dysfunction
  • Dapagliflozin 10Mg Tab
  • Placebo
  • (no location specified)
Sep 6, 2021

Type 2 Diabetes Trial (Clenbuterol Hydrochloride, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Clenbuterol Hydrochloride
  • Placebo
  • (no location specified)
Jun 2, 2021

Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in New York (Beta blocker)

Recruiting
  • Heart Failure
  • +4 more
  • Beta blocker
  • New York, New York
    Weill Cornell Medicine
Jan 31, 2023

Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
  • Fluticasone furoate/umeclidinium/vilanterol
  • Waterbury, Connecticut
  • +2 more
Apr 21, 2020

Anesthesia Intubation Complication Trial in Zagazig (Nebulized Dexmedetomidine, Nebulized Lidocaine, Intravenous

Not yet recruiting
  • Anesthesia Intubation Complication
  • Nebulized Dexmedetomidine
  • +3 more
  • Zagazig, Al-Sharkia, Egypt
    Faculty of medicine, Zagazig University
Jul 4, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 14, 2023

Cystic Fibrosis, CFTR Gene Dysfunction Trial (Beta Adrenergic Sweat Test)

Withdrawn
  • Cystic Fibrosis
  • CFTR Gene Dysfunction
  • Beta Adrenergic Sweat Test
  • (no location specified)
Jul 12, 2021

Acute Coronary Syndrome Trial in Naples (Carvedilol, Metoprolol)

Completed
  • Acute Coronary Syndrome
  • Naples, Italy
    Federico II University of Naples
Mar 15, 2022

Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,

Active, not recruiting
  • Dilated Cardiomyopathies, Idiopathic
  • +3 more
  • Aurora, Colorado
  • +1 more
Oct 31, 2022

Coronary Artery Bypass Trial in New Haven (Discontinuing all beta-blocker)

Recruiting
  • Coronary Artery Bypass
  • Discontinuing all beta-blocker
  • New Haven, Connecticut
    Yale New Haven Hospital
Nov 17, 2022

Prostate Cancer Trial in Bronx (Carvedilol)

Active, not recruiting
  • Prostate Cancer
  • Bronx, New York
    Montefiore Medical Center
Feb 18, 2021

Heart Failure With Preserved Ejection Fraction Trial in Farmington (beta blocker discontinuation)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • beta blocker discontinuation
  • Farmington, Connecticut
    UConn Health / John Dempsey Hospital
Mar 2, 2022

Angina, Stable Ischemic Heart Disease Trial in United States (Clinician Discretion, Beta blocker, Calcium channel blocker)

Not yet recruiting
  • Angina
  • Stable Ischemic Heart Disease
  • Clinician Discretion
  • +2 more
  • Oakland, California
  • +4 more
Mar 23, 2023